Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Dr. Reddy's Laboratories Limited (NYSE: RDY)
RDY Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
20.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-35.10%
RDY Stock Analysis
RDY
PE Ratio:
22.7
RDY
PEG Ratio:
1.4
RDY
Forward EPS Growth (12 month):
16.20%
RDY
PS Ratio:
2.9
RDY
PSG Ratio:
0.3
RDY
Forward Revenue Growth (12 month):
9.20%
RDY Articles
No data was found